Uploaded image for project: 'FHIR Specification Feedback'
  1. FHIR Specification Feedback
  2. FHIR-38393

Clarify "normative" status of COVID workflow

    XMLWordPrintableJSON

Details

    • Icon: Change Request Change Request
    • Resolution: Persuasive
    • Icon: Highest Highest
    • At-Home In-Vitro Test Report (FHIR)
    • 1.0.0-ballot
    • Orders & Observations
    • Workflow
    • 5.1
    • Hide

      We will re-work this whole section.

      The COVID use case and associated workflow is normative for COVID-19 at home test kits.

      We will also add another informative section that lays out a generic/typical work flow for other use cases.

      (Will also update COVID-19 like to COVID-19-like).

      We will get approval on the exact wording of the new text by the commenter before we publish.

      Show
      We will re-work this whole section. The COVID use case and associated workflow is normative for COVID-19 at home test kits. We will also add another informative section that lays out a generic/typical work flow for other use cases. (Will also update COVID-19 like to COVID-19-like). We will get approval on the exact wording of the new text by the commenter before we publish.
    • Sarah Gaunt / Riki Merrick : 6 - 0 - 3
    • Clarification
    • Non-substantive

    Description

      The status of the COVID use case is unclear. Is this a generic use case made more realistic by use of the COVID example, or is this a COVID-specific use case? Clarify which portions of this page are "normative" workflow, and which are "colour commentary".

      Consider current text compared to:
      The at-home in-vitro test report use case starts when a patient purchases an over-the-counter (OTC) test or receives an ordered test kit, for example, a COVID-19 at-home in-vitro test.

      Similarly, "the patient is asked questions by the app": do they have to be? Is this a workflow requirement? The whole workflow needs to be recast to identify what here is an example or typical workflow, and what is required from the IG. (Aside, "COVID-19 like symptoms" should be "COVID-19-like symptoms"

      Existing Wording:

      Workflow (using the COVID-19 At-Home In-Vitro Test Report use case)

      The process starts when a patient purchases an over the counter (OTC) test or receives an ordered COVID-19 At-Home In-Vitro Test. The patient interacts with a COVID-19 At-Home In-Vitro Test app. ...

      (Comment 18 - imported by: Ron G. Parker)

      Attachments

        Activity

          People

            minigrrl Sarah Gaunt
            esilver Elliot Silver
            Watchers:
            1 Start watching this issue

            Dates

              Created:
              Updated:
              Resolved: